A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics
Journal of Alzheimer’s Disease · 2023
DOI: 10.3233/jad-230641 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Alzheimer’s Disease, 2023. Verfasst von Andrew Pipingas und 24 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, VIC, Australia. Hauptthemen laut MEDLINE: Diet, Mediterranean, COVID-19, Cognitive Dysfunction, Dementia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Several clinical trials have examined diet and physical activity lifestyle changes as mitigation strategies for risk factors linked to cognitive decline and dementias such as Alzheimer’s disease. However, the ability to modify these behaviors longer term, to impact cognitive health has remained elusive.
Objective
The MedWalk trial’s primary aim is to investigate whether longer-term adherence to a Mediterranean-style diet and regular walking, delivered through motivational interviewing and cognitive-behavioral therapy (MI-CBT), can reduce age-associated cognitive decline and other dementia risk factors in older, independently living individuals without cognitive impairment.
Methods
MedWalk, a one-year cluster-randomized controlled trial across two Australian states, recruited 60–90-year-old people from independent living retirement villages and the wider community. Participants were assigned to either the MedWalk intervention or a control group (maintaining their usual diet and physical activity). The primary outcome is 12-month change in visual memory and learning assessed from errors on the Paired Associates Learning Task of the Cambridge Neuropsychological Test Automated Battery. Secondary outcomes include cognition, mood, cardiovascular function, biomarkers related to nutrient status and cognitive decline, MI-CBT effectiveness, Mediterranean diet adherence, physical activity, quality of life, cost-effectiveness, and health economic evaluation. Progress and Discussion: Although COVID-19 impacts over two years necessitated a reduced timeline and sample size, MedWalk retains sufficient power to address its aims and hypotheses. Baseline testing has been completed with 157 participants, who will be followed over 12 months. If successful, MedWalk will inform interventions that could substantially reduce dementia incidence and ameliorate cognitive decline in the community.
Trial registration
Registered on the Australia New Zealand Clinical Trials Registry ANZCTR 12620000978965 ( https://www.anzctr.org.au ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Mental Health and Brain Sciences, Swinburne University of Technology, Hawthorn, VIC, Australia.
- Alliance for Research in Exercise, Nutrition and Activity (ARENA), UniSA Allied Health and Human Performance & UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
- School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
- Department of Exercise Sciences, The University of Auckland, Newmarket, New Zealand.
- Holsworth Research Initiative, La Trobe University, Bendigo, VIC, Australia.
- Nutrition Dietetics and Food, School of Clinical Sciences, Monash University, Notting Hill, VIC, Australia.
Zitieren
APA
Pipingas, A., Murphy, K. J., Davis, C. R., Itsiopoulos, C., Kingsley, M., Scholey, A., Macpherson, H., Segal, L., Breckon, J., Minihane, A. M., Meyer, D., Ogden, E., Dyer, K. A., Eversteyn, E., Hardman, R. J., Poorun, K., Justice, K., Hana, M., Buckley, J. D., …, & MedWalk collaborative team (2023). A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-230641
Vancouver
Pipingas A, Murphy KJ, Davis CR, Itsiopoulos C, Kingsley M, Scholey A, et al. A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics. Journal of Alzheimer’s Disease. 2023. doi:10.3233/jad-230641
BibTeX
@article{Pipingas2023,
author = {Pipingas, Andrew and Murphy, Karen J and Davis, Courtney R and Itsiopoulos, Catherine and Kingsley, Michael and Scholey, Andrew and Macpherson, Helen and Segal, Leonie and Breckon, Jeff and Minihane, Anne-Marie and Meyer, Denny and Ogden, Edward and Dyer, Kathryn A and Eversteyn, Emily and Hardman, Roy J and Poorun, Kaylass and Justice, Keri and Hana, Maher and Buckley, Jonathan D and White, David and Davison, Kade and Clark, Jessie S and Bracci, Ella L and Kennedy, Greg and MedWalk collaborative team, MedWalk collaborative team},
title = {A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics},
journal = {Journal of Alzheimer’s Disease},
year = {2023},
doi = {10.3233/jad-230641}
}
EUVIMED